287 related articles for article (PubMed ID: 27756125)
1. Engineering Specificity from Broad to Narrow: Design of a β-Lactamase Inhibitory Protein (BLIP) Variant That Exclusively Binds and Detects KPC β-Lactamase.
Chow DC; Rice K; Huang W; Atmar RL; Palzkill T
ACS Infect Dis; 2016 Dec; 2(12):969-979. PubMed ID: 27756125
[TBL] [Abstract][Full Text] [Related]
2. Development and Evaluation of a Novel Protein-Based Assay for Specific Detection of KPC β-Lactamases from Klebsiella pneumoniae Clinical Isolates.
Lu S; Soeung V; Nguyen HAT; Long SW; Musser JM; Palzkill T
mSphere; 2020 Jan; 5(1):. PubMed ID: 31915233
[TBL] [Abstract][Full Text] [Related]
3. Systematic substitutions at BLIP position 50 result in changes in binding specificity for class A β-lactamases.
Adamski CJ; Palzkill T
BMC Biochem; 2017 Mar; 18(1):2. PubMed ID: 28264645
[TBL] [Abstract][Full Text] [Related]
4. Tackling the Antibiotic Resistance Caused by Class A
Eiamphungporn W; Schaduangrat N; Malik AA; Nantasenamat C
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30061509
[TBL] [Abstract][Full Text] [Related]
5. Structural and biochemical characterization of the interaction between KPC-2 beta-lactamase and beta-lactamase inhibitor protein.
Hanes MS; Jude KM; Berger JM; Bonomo RA; Handel TM
Biochemistry; 2009 Oct; 48(39):9185-93. PubMed ID: 19731932
[TBL] [Abstract][Full Text] [Related]
6. Binding properties of a peptide derived from beta-lactamase inhibitory protein.
Rudgers GW; Huang W; Palzkill T
Antimicrob Agents Chemother; 2001 Dec; 45(12):3279-86. PubMed ID: 11709298
[TBL] [Abstract][Full Text] [Related]
7. Role of β-lactamase residues in a common interface for binding the structurally unrelated inhibitory proteins BLIP and BLIP-II.
Fryszczyn BG; Adamski CJ; Brown NG; Rice K; Huang W; Palzkill T
Protein Sci; 2014 Sep; 23(9):1235-46. PubMed ID: 24947275
[TBL] [Abstract][Full Text] [Related]
8. Contributions of aspartate 49 and phenylalanine 142 residues of a tight binding inhibitory protein of beta-lactamases.
Petrosino J; Rudgers G; Gilbert H; Palzkill T
J Biol Chem; 1999 Jan; 274(4):2394-400. PubMed ID: 9891008
[TBL] [Abstract][Full Text] [Related]
9. Interdomain flexibility and interfacial integrity of β-lactamase inhibitory protein (BLIP) modulate its binding to class A β-lactamases.
Huang L; So PK; Chen YW; Leung YC; Yao ZP
J Biol Chem; 2021 Aug; 297(2):100980. PubMed ID: 34302811
[TBL] [Abstract][Full Text] [Related]
10. Identification of a β-lactamase inhibitory protein variant that is a potent inhibitor of Staphylococcus PC1 β-lactamase.
Yuan J; Chow DC; Huang W; Palzkill T
J Mol Biol; 2011 Mar; 406(5):730-44. PubMed ID: 21238457
[TBL] [Abstract][Full Text] [Related]
11. Fine mapping of the sequence requirements for binding of beta-lactamase inhibitory protein (BLIP) to TEM-1 beta-lactamase using a genetic screen for BLIP function.
Yuan J; Huang W; Chow DC; Palzkill T
J Mol Biol; 2009 Jun; 389(2):401-12. PubMed ID: 19389404
[TBL] [Abstract][Full Text] [Related]
12. Identification of the β-lactamase inhibitor protein-II (BLIP-II) interface residues essential for binding affinity and specificity for class A β-lactamases.
Brown NG; Chow DC; Ruprecht KE; Palzkill T
J Biol Chem; 2013 Jun; 288(24):17156-66. PubMed ID: 23625930
[TBL] [Abstract][Full Text] [Related]
13. Insight into Structure-Function Relationships of β-Lactamase and BLIPs Interface Plasticity using Protein-Protein Interactions.
Yadav TC; Agarwal V; Srivastava AK; Raghuwanshi N; Varadwaj P; Prasad R; Pruthi V
Curr Pharm Des; 2019; 25(31):3378-3389. PubMed ID: 31544712
[TBL] [Abstract][Full Text] [Related]
14. Variants of β-lactamase KPC-2 that are resistant to inhibition by avibactam.
Papp-Wallace KM; Winkler ML; Taracila MA; Bonomo RA
Antimicrob Agents Chemother; 2015 Jul; 59(7):3710-7. PubMed ID: 25666153
[TBL] [Abstract][Full Text] [Related]
15. Computational redesign of the SHV-1 beta-lactamase/beta-lactamase inhibitor protein interface.
Reynolds KA; Hanes MS; Thomson JM; Antczak AJ; Berger JM; Bonomo RA; Kirsch JF; Handel TM
J Mol Biol; 2008 Oct; 382(5):1265-75. PubMed ID: 18775544
[TBL] [Abstract][Full Text] [Related]
16. BLIP-II Employs Differential Hotspot Residues To Bind Structurally Similar Staphylococcus aureus PBP2a and Class A β-Lactamases.
Adamski CJ; Palzkill T
Biochemistry; 2017 Feb; 56(8):1075-1084. PubMed ID: 28182405
[TBL] [Abstract][Full Text] [Related]
17. Dissecting the protein-protein interface between beta-lactamase inhibitory protein and class A beta-lactamases.
Zhang Z; Palzkill T
J Biol Chem; 2004 Oct; 279(41):42860-6. PubMed ID: 15284234
[TBL] [Abstract][Full Text] [Related]
18. Determinants of binding affinity and specificity for the interaction of TEM-1 and SME-1 beta-lactamase with beta-lactamase inhibitory protein.
Zhang Z; Palzkill T
J Biol Chem; 2003 Nov; 278(46):45706-12. PubMed ID: 12933802
[TBL] [Abstract][Full Text] [Related]
19. Structural and computational characterization of the SHV-1 beta-lactamase-beta-lactamase inhibitor protein interface.
Reynolds KA; Thomson JM; Corbett KD; Bethel CR; Berger JM; Kirsch JF; Bonomo RA; Handel TM
J Biol Chem; 2006 Sep; 281(36):26745-53. PubMed ID: 16809340
[TBL] [Abstract][Full Text] [Related]
20. Design of potent beta-lactamase inhibitors by phage display of beta-lactamase inhibitory protein.
Huang W; Zhang Z; Palzkill T
J Biol Chem; 2000 May; 275(20):14964-8. PubMed ID: 10748011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
